Keymed Biosciences Inc. (HKG:2162)

Keymed Biosciences Revenue

Keymed Biosciences had revenue of 498.75M CNY in the half year ending June 30, 2025, with 52.47% growth. This brings the company's revenue in the last twelve months to 872.19M, up 968.17% year-over-year. In the year 2024, Keymed Biosciences had annual revenue of 428.12M with 20.91% growth.

• Revenue (ttm): 872.19M CNY
• Revenue Growth: +968.17%
• P/S Ratio: 21.67
• Revenue / Employee: 693.32K CNY
• Employees: 1,258
• Market Cap: 20.71B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	428.12M	74.03M	20.91%
Dec 31, 2023	354.10M	254.03M	253.87%
Dec 31, 2022	100.06M	-10.21M	-9.26%
Dec 31, 2021	110.27M	-	-
Dec 31, 2020	-	-	-